A new generation of topical chronic wound treatments containing specific MMP inhibitors
Ravi Shrivastava, Nathalie Cucuat, Monika Rousse, Thomas Weigand, Pedro Neto, Claire Janicot, Christiane Shrivastava VITROBIO Research Institute, Issoire, France Purpose: Incidence of chronic wounds is constantly rising worldwide, but all currently available treatments are intended either to provid...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-09-01
|
Series: | Chronic Wound Care Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/a-new-generation-of-topical-chronic-wound-treatments-containing-specif-peer-reviewed-article-CWCMR |
id |
doaj-05462ba4264a4bffbf65d03e2c92ac9f |
---|---|
record_format |
Article |
spelling |
doaj-05462ba4264a4bffbf65d03e2c92ac9f2020-11-24T23:36:39ZengDove Medical PressChronic Wound Care Management and Research2324-481X2014-09-012014Issue 1314018209A new generation of topical chronic wound treatments containing specific MMP inhibitorsShrivastava RCucuat NRousse MWeigTNeto PJanicot CShrivastava CRavi Shrivastava, Nathalie Cucuat, Monika Rousse, Thomas Weigand, Pedro Neto, Claire Janicot, Christiane Shrivastava VITROBIO Research Institute, Issoire, France Purpose: Incidence of chronic wounds is constantly rising worldwide, but all currently available treatments are intended either to provide symptomatic relief or to assist cicatrization to some extent, but not to directly stimulate cellular growth. Physiologically, chronic wound healing simply requires cell growth to fill the injured cavity. To grow, our cells need to attach onto a cushion, called extracellular matrix (ECM), secreted by the mother cells and composed of multiple proteins. Recent scientific works prove that the concentration of certain matrix metalloproteinases (MMPs) is extremely high in all chronic wounds and, because of their proteolytic nature, some MMPs completely degrade the ECM, hindering cell attachment and cell growth. The aim of this study was to identify, neutralize, and eliminate these MMPs from the wound surface so as to design an effective treatment for chronic wounds. Methods: Acute and chronic models of human epithelial and fibroblast cells were prepared on a defined ECM cushion in vitro and MMPs were added in the culture medium to identify the MMPs causing ECM disintegration for each cell type. ECM-degrading MMPs were then incubated with selected procyanidin-rich plant extracts (PCDs) and cell growth was reanalyzed. Results: It was observed that: 1) multiple MMPs are involved in cellular matrix destruction; 2) ECM-destroying MMPs are specific with respect to cell type; and 3) specific PCDs may bind and neutralize selected MMPs. Conclusion: Topical application of specific plant PCDs to selectively neutralize ECM-destroying MMPs in acute and chronic wounds represents a novel approach for the treatment of superficial and deep skin wounds. Keywords: extra cellular matrix (ECM), matrix metalloproteinases, procyanidins (PCDs), tannins, ulcershttps://www.dovepress.com/a-new-generation-of-topical-chronic-wound-treatments-containing-specif-peer-reviewed-article-CWCMRExtra Cellular Matrix (ECM)matrix metalloproteinasesprocyanidins (PCDs)tanninsulcers. |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shrivastava R Cucuat N Rousse M Weig T Neto P Janicot C Shrivastava C |
spellingShingle |
Shrivastava R Cucuat N Rousse M Weig T Neto P Janicot C Shrivastava C A new generation of topical chronic wound treatments containing specific MMP inhibitors Chronic Wound Care Management and Research Extra Cellular Matrix (ECM) matrix metalloproteinases procyanidins (PCDs) tannins ulcers. |
author_facet |
Shrivastava R Cucuat N Rousse M Weig T Neto P Janicot C Shrivastava C |
author_sort |
Shrivastava R |
title |
A new generation of topical chronic wound treatments containing specific MMP inhibitors |
title_short |
A new generation of topical chronic wound treatments containing specific MMP inhibitors |
title_full |
A new generation of topical chronic wound treatments containing specific MMP inhibitors |
title_fullStr |
A new generation of topical chronic wound treatments containing specific MMP inhibitors |
title_full_unstemmed |
A new generation of topical chronic wound treatments containing specific MMP inhibitors |
title_sort |
new generation of topical chronic wound treatments containing specific mmp inhibitors |
publisher |
Dove Medical Press |
series |
Chronic Wound Care Management and Research |
issn |
2324-481X |
publishDate |
2014-09-01 |
description |
Ravi Shrivastava, Nathalie Cucuat, Monika Rousse, Thomas Weigand, Pedro Neto, Claire Janicot, Christiane Shrivastava VITROBIO Research Institute, Issoire, France Purpose: Incidence of chronic wounds is constantly rising worldwide, but all currently available treatments are intended either to provide symptomatic relief or to assist cicatrization to some extent, but not to directly stimulate cellular growth. Physiologically, chronic wound healing simply requires cell growth to fill the injured cavity. To grow, our cells need to attach onto a cushion, called extracellular matrix (ECM), secreted by the mother cells and composed of multiple proteins. Recent scientific works prove that the concentration of certain matrix metalloproteinases (MMPs) is extremely high in all chronic wounds and, because of their proteolytic nature, some MMPs completely degrade the ECM, hindering cell attachment and cell growth. The aim of this study was to identify, neutralize, and eliminate these MMPs from the wound surface so as to design an effective treatment for chronic wounds. Methods: Acute and chronic models of human epithelial and fibroblast cells were prepared on a defined ECM cushion in vitro and MMPs were added in the culture medium to identify the MMPs causing ECM disintegration for each cell type. ECM-degrading MMPs were then incubated with selected procyanidin-rich plant extracts (PCDs) and cell growth was reanalyzed. Results: It was observed that: 1) multiple MMPs are involved in cellular matrix destruction; 2) ECM-destroying MMPs are specific with respect to cell type; and 3) specific PCDs may bind and neutralize selected MMPs. Conclusion: Topical application of specific plant PCDs to selectively neutralize ECM-destroying MMPs in acute and chronic wounds represents a novel approach for the treatment of superficial and deep skin wounds. Keywords: extra cellular matrix (ECM), matrix metalloproteinases, procyanidins (PCDs), tannins, ulcers |
topic |
Extra Cellular Matrix (ECM) matrix metalloproteinases procyanidins (PCDs) tannins ulcers. |
url |
https://www.dovepress.com/a-new-generation-of-topical-chronic-wound-treatments-containing-specif-peer-reviewed-article-CWCMR |
work_keys_str_mv |
AT shrivastavar anewgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors AT cucuatn anewgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors AT roussem anewgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors AT weig anewgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors AT t anewgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors AT netop anewgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors AT janicotc anewgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors AT shrivastavac anewgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors AT shrivastavar newgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors AT cucuatn newgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors AT roussem newgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors AT weig newgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors AT t newgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors AT netop newgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors AT janicotc newgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors AT shrivastavac newgenerationoftopicalchronicwoundtreatmentscontainingspecificmmpinhibitors |
_version_ |
1725522077971120128 |